HAO HAO
Company Profile ↓Company Overview
HAO (HAO) is a publicly traded company listed on with a market capitalization of $3.62K. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 129.8% per year over the last five years.
Revenue has grown at a 73.3% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.11.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue +71.9%, earnings +33.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 73.3%, profit CAGR 129.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 73.29% |
| 1 Year: | 71.88% |
Compounded Profit Growth
| 5 Years: | 129.80% |
| 1 Year: | 33.20% |
Stock Price Performance
| 1 Year: | -99.90% |
| 6 Months: | -99.91% |
| 3 Months: | -99.81% |
| 1 Month: | -85.50% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)15.00 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 73.3% over 5 years.
- Profit CAGR of 129.8% over 5 years.
CONS
- Trading 99.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
- RSI at 15 suggests oversold conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 16.16M | 28.23M | 48.52M | - |
| Cost of Revenue | 15.51M | 26.17M | 45.77M | - |
| Gross Profit | 648.72K | 2.06M | 2.75M | - |
| Operating Expenses | 379.95K | 866.25K | 1.03M | - |
| Operating Income | 268.77K | 1.20M | 1.72M | - |
| EBITDA | 271.77K | 1.22M | 1.79M | - |
| Interest Expense | 9.96K | 20.90K | 41.19K | - |
| Pretax Income | 259.60K | 1.19M | 1.74M | - |
| Tax Provision | 15.01K | 220.65K | 443.58K | - |
| Net Income | 244.59K | 969.75K | 1.29M | - |
| Diluted EPS | 17.89 | 111.36 | 135.68 | 168.96 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Total Assets | 542.99K | 4.46M | 15.51M | - |
| Current Assets | 445.06K | 3.67M | 15.38M | - |
| Cash & Equivalents | 293.51K | 1.20M | 6.66M | - |
| Inventory | - | - | - | - |
| Receivables | 3.92K | 7.75K | 226.75K | - |
| Total Liabilities | 2.01M | 2.90M | 4.23M | - |
| Current Liabilities | 2.01M | 2.58M | 3.87M | - |
| Long Term Debt | - | 249.11K | 368.04K | - |
| Total Debt | 505.40K | 850.06K | 1.20M | - |
| Total Equity | -1.47M | 1.57M | 11.27M | - |
| Shares Outstanding | 9.96K | 9.96K | 10.07K | 22.63K |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Operating Cash Flow | -675.36K | -872.13K | -747.58K |
| Investing Cash Flow | -8.70K | -45.50K | -3.13M |
| Financing Cash Flow | 933.22K | 1.80M | 9.32M |
| Capital Expenditure | -8.70K | -45.50K | -55.37K |
| Free Cash Flow | -684.06K | -917.63K | -802.94K |
| Net Change in Cash | 249.16K | 884.94K | 5.45M |
Ratios (Annual)
Figures in %.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Gross Margin % | 4.0% | 7.3% | 5.7% | - |
| Operating Margin % | 1.7% | 4.2% | 3.5% | - |
| Net Margin % | 1.5% | 3.4% | 2.7% | - |
| ROE % | -16.7% | 61.9% | 11.5% | - |
| ROCE % | -18.3% | 63.3% | 14.8% | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HAO
Haoxi Health lines up $4 million share sale at $0.40 each - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQaXFOODMtM3NKRXZ0WDVFd3NEY1lpM1VxTnJwcFp2NF8zczRjbF9CRC1WNVlYOXRGSWZ2S1dGVHV4dFZWWVFTZHM3QW9xRmFidTNNamJSV3lraWFfR3NUZEc4czZ0dGtGNjlIVzNqeWJObTBoU3pmb2RwbVhlZzVuQXVlRjljWmVKTXZpZW…
Insider Purchase: CEO & Chairman of $HAO Buys 40,000,000 Shares - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQY2FjaUxMZXltQ3JWaFRDanRBdTRmRWpNZXBFbWNyd0RxYWZLTTNudUVfOHhXYkhIaHF4bHNrSnp6OHZqbmtMNW1PN2NDdHhWc1hyZDFVOXNGUWxJQzh3dW1saXpDOXNGYWJkTGo0c3NJTTY5QW53N05jM0NLdGdBaHVUMEZBQnNtOHB3bT…
Registered Direct Offering Raises Dilution Questions for Haoxi Health Technology - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQeFo1dWZsMmd1cXkxN0hzTERaSmg3T21qQmJjYmFSbzZHY2tpdURzN1A0MURoeDZ6NHQ1T0JzYWZ1VWZMY0ZFTFVxbDFCSmhxckotb0FvVTFjUklETFRFTWpxd1NLV0RIY3BuTkJscjM5SS0wTmNQN0Rfd1pYSjBpWllXeS1vcFFNV0Jib3…
Haoxi Health Technology Limited Announces 1-For-128 Reverse Share Split - GlobeNewswire
<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxQOHNXTGJjLWFpSHpsMnpfN2RxS0VwOFRUS09fTGhZdGwteDZEbFp1Sm9aOEphWkFMZl9xUENyWnJQSHBCTVlacVJweDJuNEpEY0xQdlMyQ0M4cjlaTUd5aGp4YVhiWjNFRG5qZ2cwVXFXTU5xWDJHX0x4a3JhVWVzVnp1S1l3SkNKUVp4cl…
Haoxi Health Technology Ltd (HAO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTFBXTS1ONWZDZmZTRWJENEJheDUyamZkZjdKTnFVS1o0bUY3eHRVaEU4eURSOXFVQ2pzSnFSMlJaczFPNldTcVFQNERIWkk2M3A5bkNOWmQ0Q3k1WlFoVXdzNy05UzE?oc=5" target="_blank">Haoxi Health Technology Ltd (HAO…
Haoxi Health Technology Raises Up to $4 Million in Registered Direct Offering with Pre-Funded Warrants - theglobeandmail.com
<a href="https://news.google.com/rss/articles/CBMilgJBVV95cUxNRFpCdDIxYl9wLU92QnBSSk9jbDJrcG1vSkMwTTRBQnp4b0M2emtIdlNzekt2NFlYdmxFVGw0RUpPT0dkaURkcUk0bGtBbmVyQ0tTcTYwc3BMTVR3Q0RXclZweTBjdzhlZjFEbXV0RzJPX0NMZHYydmdMN3dVdmJ6VVdHVEZOcEJreERESj…
HAO — Frequently Asked Questions
What is the current share price of HAO?
As of 2026-08-05 17:25 PDT, HAO trades at $0.16 on NASDAQ/NYSE. Its 52-week range is $0.15 to $204.80.
What is the market capitalisation of HAO?
HAO has a market capitalisation of $3.62K on NASDAQ/NYSE.
What is the return on equity (ROE) of HAO?
HAO has a return on equity (ROE) of 11.46%. Its return on capital employed (ROCE) is 14.75%.
Is HAO a good stock to buy?
This page provides a data-driven analysis of HAO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.